List of Tables
Table 1. Targeted Drugs for Colorectal Cancer Market Trends
Table 2. Targeted Drugs for Colorectal Cancer Market Drivers & Opportunity
Table 3. Targeted Drugs for Colorectal Cancer Market Challenges
Table 4. Targeted Drugs for Colorectal Cancer Market Restraints
Table 5. Global Targeted Drugs for Colorectal Cancer Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Targeted Drugs for Colorectal Cancer Revenue Market Share by Company (2019-2024)
Table 7. Global Targeted Drugs for Colorectal Cancer Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Targeted Drugs for Colorectal Cancer Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Targeted Drugs for Colorectal Cancer Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Targeted Drugs for Colorectal Cancer Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Targeted Drugs for Colorectal Cancer Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Targeted Drugs for Colorectal Cancer
Table 13. Global Targeted Drugs for Colorectal Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drugs for Colorectal Cancer as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Targeted Drugs for Colorectal Cancer Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Targeted Drugs for Colorectal Cancer Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Targeted Drugs for Colorectal Cancer Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Targeted Drugs for Colorectal Cancer Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Targeted Drugs for Colorectal Cancer Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Targeted Drugs for Colorectal Cancer Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Targeted Drugs for Colorectal Cancer Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Targeted Drugs for Colorectal Cancer Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Targeted Drugs for Colorectal Cancer Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Targeted Drugs for Colorectal Cancer Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Targeted Drugs for Colorectal Cancer Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Targeted Drugs for Colorectal Cancer Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Targeted Drugs for Colorectal Cancer Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Targeted Drugs for Colorectal Cancer Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Targeted Drugs for Colorectal Cancer Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Targeted Drugs for Colorectal Cancer Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Targeted Drugs for Colorectal Cancer Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Targeted Drugs for Colorectal Cancer Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Targeted Drugs for Colorectal Cancer Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Targeted Drugs for Colorectal Cancer Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Targeted Drugs for Colorectal Cancer Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Targeted Drugs for Colorectal Cancer Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Targeted Drugs for Colorectal Cancer Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Targeted Drugs for Colorectal Cancer Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Targeted Drugs for Colorectal Cancer Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Targeted Drugs for Colorectal Cancer Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Targeted Drugs for Colorectal Cancer Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Targeted Drugs for Colorectal Cancer Sales Value by Region (2019-2024) & (%)
Table 44. Global Targeted Drugs for Colorectal Cancer Sales Value by Region (2025-2030) & (%)
Table 45. Global Targeted Drugs for Colorectal Cancer Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Targeted Drugs for Colorectal Cancer Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Targeted Drugs for Colorectal Cancer Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Targeted Drugs for Colorectal Cancer Sales Volume by Region (2019-2024) & (%)
Table 49. Global Targeted Drugs for Colorectal Cancer Sales Volume by Region (2025-2030) & (%)
Table 50. Global Targeted Drugs for Colorectal Cancer Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Targeted Drugs for Colorectal Cancer Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Targeted Drugs for Colorectal Cancer Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Targeted Drugs for Colorectal Cancer Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Targeted Drugs for Colorectal Cancer Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Targeted Drugs for Colorectal Cancer Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Targeted Drugs for Colorectal Cancer Sales Volume, (2025-2030) & (K Units)
Table 57. Merck Company Information
Table 58. Merck Introduction and Business Overview
Table 59. Merck Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Merck Targeted Drugs for Colorectal Cancer Product Offerings
Table 61. Merck Recent Development
Table 62. Amgen Company Information
Table 63. Amgen Introduction and Business Overview
Table 64. Amgen Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Amgen Targeted Drugs for Colorectal Cancer Product Offerings
Table 66. Amgen Recent Development
Table 67. F. Hoffmann-La Roche Ltd Company Information
Table 68. F. Hoffmann-La Roche Ltd Introduction and Business Overview
Table 69. F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Product Offerings
Table 71. F. Hoffmann-La Roche Ltd Recent Development
Table 72. Novartis Company Information
Table 73. Novartis Introduction and Business Overview
Table 74. Novartis Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Novartis Targeted Drugs for Colorectal Cancer Product Offerings
Table 76. Novartis Recent Development
Table 77. Array BioPharma Company Information
Table 78. Array BioPharma Introduction and Business Overview
Table 79. Array BioPharma Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Array BioPharma Targeted Drugs for Colorectal Cancer Product Offerings
Table 81. Array BioPharma Recent Development
Table 82. Genentech Company Information
Table 83. Genentech Introduction and Business Overview
Table 84. Genentech Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Genentech Targeted Drugs for Colorectal Cancer Product Offerings
Table 86. Genentech Recent Development
Table 87. Bayer Company Information
Table 88. Bayer Introduction and Business Overview
Table 89. Bayer Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Bayer Targeted Drugs for Colorectal Cancer Product Offerings
Table 91. Bayer Recent Development
Table 92. Sanofi Company Information
Table 93. Sanofi Introduction and Business Overview
Table 94. Sanofi Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Sanofi Targeted Drugs for Colorectal Cancer Product Offerings
Table 96. Sanofi Recent Development
Table 97. Lilly Company Information
Table 98. Lilly Introduction and Business Overview
Table 99. Lilly Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Lilly Targeted Drugs for Colorectal Cancer Product Offerings
Table 101. Lilly Recent Development
Table 102. Bristol myers squibb Company Information
Table 103. Bristol myers squibb Introduction and Business Overview
Table 104. Bristol myers squibb Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Bristol myers squibb Targeted Drugs for Colorectal Cancer Product Offerings
Table 106. Bristol myers squibb Recent Development
Table 107. MSD lreland Company Information
Table 108. MSD lreland Introduction and Business Overview
Table 109. MSD lreland Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. MSD lreland Targeted Drugs for Colorectal Cancer Product Offerings
Table 111. MSD lreland Recent Development
Table 112. HUTCHMED Company Information
Table 113. HUTCHMED Introduction and Business Overview
Table 114. HUTCHMED Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. HUTCHMED Targeted Drugs for Colorectal Cancer Product Offerings
Table 116. HUTCHMED Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Targeted Drugs for Colorectal Cancer Downstream Customers
Table 120. Targeted Drugs for Colorectal Cancer Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Targeted Drugs for Colorectal Cancer Product Picture
Figure 2. Global Targeted Drugs for Colorectal Cancer Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Targeted Drugs for Colorectal Cancer Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Targeted Drugs for Colorectal Cancer Sales Volume (2019-2030) & (K Units)
Figure 5. Global Targeted Drugs for Colorectal Cancer Sales Price (2019-2030) & (US$/Unit)
Figure 6. Targeted Drugs for Colorectal Cancer Report Years Considered
Figure 7. Global Targeted Drugs for Colorectal Cancer Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Targeted Drugs for Colorectal Cancer Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Targeted Drugs for Colorectal Cancer Revenue in 2023
Figure 10. Targeted Drugs for Colorectal Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. EGFR Target Picture
Figure 12. BRAF Target Picture
Figure 13. MEK1/2 Targets Picture
Figure 14. BRAF V600 Target Picture
Figure 15. HER2 Target Picture
Figure 16. VEGFR-1/2/3 Targets Picture
Figure 17. PD-1 Target Picture
Figure 18. CTLA-4 Target Picture
Figure 19. Global Targeted Drugs for Colorectal Cancer Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Targeted Drugs for Colorectal Cancer Sales Value Market Share by Type, 2023 & 2030
Figure 21. Global Targeted Drugs for Colorectal Cancer Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 22. Global Targeted Drugs for Colorectal Cancer Sales Volume Market Share by Type, 2023 & 2030
Figure 23. Global Targeted Drugs for Colorectal Cancer Price by Type (2019-2030) & (US$/Unit)
Figure 24. Product Picture of Hospital
Figure 25. Product Picture of Specialty Clinic
Figure 26. Global Targeted Drugs for Colorectal Cancer Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Targeted Drugs for Colorectal Cancer Sales Value Market Share by Application, 2023 & 2030
Figure 28. Global Targeted Drugs for Colorectal Cancer Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 29. Global Targeted Drugs for Colorectal Cancer Sales Volume Market Share by Application, 2023 & 2030
Figure 30. Global Targeted Drugs for Colorectal Cancer Price by Application (2019-2030) & (US$/Unit)
Figure 31. North America Targeted Drugs for Colorectal Cancer Sales Value (2019-2030) & (US$ Million)
Figure 32. North America Targeted Drugs for Colorectal Cancer Sales Value by Country (%), 2023 VS 2030
Figure 33. Europe Targeted Drugs for Colorectal Cancer Sales Value (2019-2030) & (US$ Million)
Figure 34. Europe Targeted Drugs for Colorectal Cancer Sales Value by Country (%), 2023 VS 2030
Figure 35. Asia Pacific Targeted Drugs for Colorectal Cancer Sales Value (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Targeted Drugs for Colorectal Cancer Sales Value by Country (%), 2023 VS 2030
Figure 37. South America Targeted Drugs for Colorectal Cancer Sales Value (2019-2030) & (US$ Million)
Figure 38. South America Targeted Drugs for Colorectal Cancer Sales Value by Country (%), 2023 VS 2030
Figure 39. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Value (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Value by Country (%), 2023 VS 2030
Figure 41. Key Countries/Regions Targeted Drugs for Colorectal Cancer Sales Value (%), (2019-2030)
Figure 42. Key Countries/Regions Targeted Drugs for Colorectal Cancer Sales Volume (%), (2019-2030)
Figure 43. United States Targeted Drugs for Colorectal Cancer Sales Value, (2019-2030) & (US$ Million)
Figure 44. United States Targeted Drugs for Colorectal Cancer Sales Value by Type (%), 2023 VS 2030
Figure 45. United States Targeted Drugs for Colorectal Cancer Sales Value by Application (%), 2023 VS 2030
Figure 46. Europe Targeted Drugs for Colorectal Cancer Sales Value, (2019-2030) & (US$ Million)
Figure 47. Europe Targeted Drugs for Colorectal Cancer Sales Value by Type (%), 2023 VS 2030
Figure 48. Europe Targeted Drugs for Colorectal Cancer Sales Value by Application (%), 2023 VS 2030
Figure 49. China Targeted Drugs for Colorectal Cancer Sales Value, (2019-2030) & (US$ Million)
Figure 50. China Targeted Drugs for Colorectal Cancer Sales Value by Type (%), 2023 VS 2030
Figure 51. China Targeted Drugs for Colorectal Cancer Sales Value by Application (%), 2023 VS 2030
Figure 52. Japan Targeted Drugs for Colorectal Cancer Sales Value, (2019-2030) & (US$ Million)
Figure 53. Japan Targeted Drugs for Colorectal Cancer Sales Value by Type (%), 2023 VS 2030
Figure 54. Japan Targeted Drugs for Colorectal Cancer Sales Value by Application (%), 2023 VS 2030
Figure 55. South Korea Targeted Drugs for Colorectal Cancer Sales Value, (2019-2030) & (US$ Million)
Figure 56. South Korea Targeted Drugs for Colorectal Cancer Sales Value by Type (%), 2023 VS 2030
Figure 57. South Korea Targeted Drugs for Colorectal Cancer Sales Value by Application (%), 2023 VS 2030
Figure 58. Southeast Asia Targeted Drugs for Colorectal Cancer Sales Value, (2019-2030) & (US$ Million)
Figure 59. Southeast Asia Targeted Drugs for Colorectal Cancer Sales Value by Type (%), 2023 VS 2030
Figure 60. Southeast Asia Targeted Drugs for Colorectal Cancer Sales Value by Application (%), 2023 VS 2030
Figure 61. India Targeted Drugs for Colorectal Cancer Sales Value, (2019-2030) & (US$ Million)
Figure 62. India Targeted Drugs for Colorectal Cancer Sales Value by Type (%), 2023 VS 2030
Figure 63. India Targeted Drugs for Colorectal Cancer Sales Value by Application (%), 2023 VS 2030
Figure 64. Targeted Drugs for Colorectal Cancer Industrial Chain
Figure 65. Targeted Drugs for Colorectal Cancer Manufacturing Cost Structure
Figure 66. Channels of Distribution (Direct Sales, and Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
